Trikafta 100-50-75 MG/75MG PKT 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FDDR9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,056
Award facts
- Contract value 100% obligated
- $57,056.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $57,056.09 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Trikafta 100-50-75 mg tablets in quantities of 14 packets. The delivery order, awarded on December 24, 2025, with an ultimate completion date of December 26, 2025, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. holds no subcontractor relationships on this award and will perform the work at its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency designated as SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products to support Department of Defense military healthcare facilities worldwide. The PPV-G GEN V represents a $30.3 billion acquisition strategy, with DMS Pharmaceutical Group positioned as one of multiple regional prime vendor contractors serving critical pharmaceutical supply needs across the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DR26FDDR9?
SPE2DR26FDDR9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 24, 2025.
How much is contract SPE2DR26FDDR9 worth?
The government has obligated $57,056 on SPE2DR26FDDR9.
Is contract SPE2DR26FDDR9 an order under another contract?
Yes. SPE2DR26FDDR9 is a delivery order under SPE2DR25D9102, an indefinite delivery contract.
Was contract SPE2DR26FDDR9 competed?
The extent of competition for SPE2DR26FDDR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award